TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11103723

Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 9248770

Group type: EXPERIMENTAL
Intervention: Oral artemether (300 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Intramuscular artemether (300 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Comparison of oral vs intramuscular artemether
Number of subjects: 8
Study: 7834482

Group type: EXPERIMENTAL
Intervention: Optiray 320 (higher-strength contrast medium)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Optiray 240 (lower-strength contrast medium)
Number of subjects: 50
Study: 2129004

Group type: EXPERIMENTAL
Intervention: MMC (Mitomycin C)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Alternating therapy with MMC and BCG (Bacillus Calmette-Guérin)
Number of subjects: 62

Group type: COMPARATOR
Intervention: BCG
Number of subjects: 62

Group type: COMPARATOR
Intervention: MMC
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Grade of TIS
Number of subjects: 62
Study: 361060

Group type: EXPERIMENTAL
Intervention: Diflucortolone valerate 0.3% ointment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Clobetasol propionate 0.05% ointment
Number of subjects: 20
Study: 30600865

Group type: EXPERIMENTAL
Intervention: Proactive telephone outcall intervention (3 outcalls from trained Cancer Council nurses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (3 phone call reminders of the availability of 131120 services)
Number of subjects: 0
Study: 28759502

Group type: EXPERIMENTAL
Intervention: Quadratus lumborum block
Number of subjects: 50

Group type: COMPARATOR
Intervention: Transversus abdominis plane block
Number of subjects: 50
Study: 26218142

Group type: EXPERIMENTAL
Intervention: Problem solving skills training (PSST) - 2 sessions
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Problem solving skills training (PSST) - 4 sessions
Number of subjects: 76

Group type: COMPARATOR
Intervention: Wait-list comparison group
Number of subjects: 76
Study: 25536713

Group type: EXPERIMENTAL
Intervention: Active tDCS (1 mA anodal)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Sham (placebo) tDCS
Number of subjects: 46
Study: 22905758

Group type: EXPERIMENTAL
Intervention: Dual management of malaria and pneumonia
Number of subjects: 125

Group type: COMPARATOR
Intervention: Single management of malaria
Number of subjects: 125
Study: 19752769

Group type: EXPERIMENTAL
Intervention: HF+PD (hemofiltration and peritoneal dialysis)
Number of subjects: 51
Study: 17055216

Group type: EXPERIMENTAL
Intervention: Trauma experienced (n=54)
Number of subjects: 103

Group type: COMPARATOR
Intervention: No trauma experienced (n=36)
Number of subjects: 103
Study: 15749316

Group type: EXPERIMENTAL
Intervention: Three-day course of intravenous antibiotic prophylaxis with ampicillin and netilmicin (two daily doses for 72 h)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Single bolus injection of intravenous antibiotic prophylaxis with ampicillin and netilmicin on admission
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Three-day course of intravenous antibiotic prophylaxis with ampicillin and netilmicin
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Both interventions (three-day course and bolus)
Number of subjects: 130
Study: 12131109

Group type: EXPERIMENTAL
Intervention: Propofol infusion at a rate to achieve a target plasma concentration of 0.5 microg/ml
Number of subjects: 10

Group type: COMPARATOR
Intervention: 10% Intralipid or 0.9% saline (control)
Number of subjects: 10

Group type: COMPARATOR
Intervention: All groups (including control)
Number of subjects: 10
Study: 10223928

Group type: EXPERIMENTAL
Intervention: Zafirlukast
Number of subjects: 12

Group type: COMPARATOR
Intervention: Azithromycin and Clarithromycin
Number of subjects: 12
Study: 8886780

Group type: EXPERIMENTAL
Intervention: Painful transtibial amputees
Number of subjects: 21

Group type: COMPARATOR
Intervention: Pain-free transtibial amputees
Number of subjects: 21
Study: 1858501

Group type: EXPERIMENTAL
Intervention: vitamin mineral pill with a high iron content
Number of subjects: 192

Group type: COMPARATOR
Intervention: vitamin‐mineral pill
Number of subjects: 192
Study: 6353397

Group type: EXPERIMENTAL
Intervention: 5 mg fenoterol via Hudson nebulizer
Number of subjects: 10

Group type: COMPARATOR
Intervention: 5 mg salbutamol via Hudson nebulizer
Number of subjects: 10
Study: 31618733

Group type: EXPERIMENTAL
Intervention: Levocetirizine 5 mg
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Desloratadine 5 mg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 28625505

Group type: EXPERIMENTAL
Intervention: S-amlodipine nicotinate/olmesartan medoxomil 5/40 mg (test product)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Amlodipine besylate/olmesartan medoxomil 10/40 mg (reference product)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both test and reference formulations
Number of subjects: 32
Study: 25439179

Group type: EXPERIMENTAL
Intervention: Integrated training combining insufflator module and VR skills exercises
Number of subjects: 42

Group type: COMPARATOR
Intervention: Insufflator simulation module and laparoscopic skills exercise module (control group)
Number of subjects: 42
Study: 23429831

Group type: EXPERIMENTAL
Intervention: Incentive spirometry
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (thoracic expansion exercises)
Number of subjects: 180
Study: 21310897

Group type: EXPERIMENTAL
Intervention: Treadmill Six-Minute Walk Test (Tr6MWT)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Six-Minute Walk Test (6MWT)
Number of subjects: 26
Study: 19816505

Group type: EXPERIMENTAL
Intervention: Combination therapy with olmesartan medoxomil (OLM) 20 mg plus azelnidipine (AZL) 16 mg (O/A (20/16))
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapy with olmesartan medoxomil (OLM) 10 mg plus azelnidipine (AZL) 8 mg (O/A (10/8))
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monotherapy with olmesartan medoxomil (OLM) 20 mg (OLM (20))
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monotherapy with azelnidipine (AZL) 16 mg (AZL (16))
Number of subjects: 0
Study: 16723325

Group type: EXPERIMENTAL
Intervention: Hypothyroidism
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Major depression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypothyroid state
Number of subjects: 0
Study: 15630900

Group type: EXPERIMENTAL
Intervention: Heterozygous AAT variants (MZ, MS, MF, ML, ME)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Heterozygous AAT variants
Number of subjects: 100

Group type: COMPARATOR
Intervention: Homozygous M variant
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Secondary IgAN
Number of subjects: 100
Study: 11378833

Group type: EXPERIMENTAL
Intervention: MPA 2.5 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: MPA 5 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: MPA 10 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: MPA 2.5 mg, MPA 5 mg, MPA 10 mg
Number of subjects: 20
Study: 1422991

Group type: EXPERIMENTAL
Intervention: Nitroglycerin administration
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Reverse redistribution patients
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Tomographic exercise thallium scintigraphy
Number of subjects: 63
Study: 3989036

Group type: EXPERIMENTAL
Intervention: 30 ml Gastrografin
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 20 ml Gastrografin
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: dilute barium (600 ml)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (no contrast medium)
Number of subjects: 50
Study: 30868829

Group type: EXPERIMENTAL
Intervention: Qingying Tang, 150 mL/time, twice a day for 12 weeks
Number of subjects: 72

Group type: COMPARATOR
Intervention: Acitretin Capsules, 10 mg/time, twice a day for 12 weeks
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 72
Study: 29958726

Group type: EXPERIMENTAL
Intervention: Scapular muscles strengthening along with conventional physiotherapy
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 26
Study: 27294710

Group type: EXPERIMENTAL
Intervention: Emotional words (low-valued)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition (emotional and neutral words equally valued)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall recall performance
Number of subjects: 0
Study: 25465417

Group type: EXPERIMENTAL
Intervention: Vorapaxar 2.5 mg daily
Number of subjects: 20170

Group type: EXPERIMENTAL
Intervention: Vorapaxar
Number of subjects: 20170
Study: 22222512

Group type: EXPERIMENTAL
Intervention: Parent Education Through Simulation‐Diabetes (HPS)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Hypoglycemia education enhanced with the HPS
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Instrument reliability demonstrated for all scales
Number of subjects: 16
Study: 20462978

Group type: EXPERIMENTAL
Intervention: TS-1 (40-60 mg twice daily for 28 consecutive days, followed by a 14-day rest period)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Taxanes (docetaxel 60-75 mg/m(2) at 3- or 4-week intervals, paclitaxel 175 mg/m(2) at 3- or 4-week intervals or paclitaxel 80-100 mg/m(2) weekly, followed by a 1-week rest period)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: TS-1
Number of subjects: 600

Group type: COMPARATOR
Intervention: Taxanes
Number of subjects: 600
Study: 18227320

Group type: EXPERIMENTAL
Intervention: Hyperventilation (PaCO2 = 25 +/- 2 mm Hg)
Number of subjects: 275

Group type: COMPARATOR
Intervention: Normoventilation (PaCO2 = 37 +/- 2 mm Hg)
Number of subjects: 275
Study: 16194646

Group type: EXPERIMENTAL
Intervention: 15 mg of elemental iron (liquid ferrous gluconate) for 60 days
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 150 mg of ferrous calcium citrate tablets for 60 days
Number of subjects: 90

Group type: COMPARATOR
Intervention: 15 mg of iron for 60 days (control group)
Number of subjects: 90
Study: 12651035

Group type: EXPERIMENTAL
Intervention: TMP grade 2/3
Number of subjects: 267

Group type: COMPARATOR
Intervention: Stenting
Number of subjects: 267
Study: 10813100

Group type: EXPERIMENTAL
Intervention: r‐FSH (Gonal‐F)
Number of subjects: 120

Group type: COMPARATOR
Intervention: u‐FSH‐HP (Metrodin‐HP)
Number of subjects: 120
Study: 8869799

Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Granulocyte-macrophage colony-stimulating factor (GM-CSF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Erythropoietin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: c-mpl-ligand (megakaryocyte growth and development factor or thrombopoietin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Granulocyte and granulocyte-macrophage colony-stimulating factors
Number of subjects: 0
Study: 1806546

Group type: EXPERIMENTAL
Intervention: Piroxicam-beta-cyclodextrin (20 mg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Piroxicam (20 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Piroxicam
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Piroxicam-beta-cyclodextrin
Number of subjects: 36
Study: 4009328

Group type: EXPERIMENTAL
Intervention: Narrow‐spectrum blue light
Number of subjects: 12

Group type: COMPARATOR
Intervention: Broad‐spectrum white light
Number of subjects: 12
Study: 30122305

Group type: EXPERIMENTAL
Intervention: Semaglutide 0.05 mg
Number of subjects: 957

Group type: EXPERIMENTAL
Intervention: Semaglutide 0.1 mg
Number of subjects: 957

Group type: EXPERIMENTAL
Intervention: Semaglutide 0.2 mg
Number of subjects: 957

Group type: EXPERIMENTAL
Intervention: Semaglutide 0.3 mg
Number of subjects: 957

Group type: EXPERIMENTAL
Intervention: Semaglutide 0.4 mg
Number of subjects: 957

Group type: EXPERIMENTAL
Intervention: Liraglutide 3.0 mg
Number of subjects: 957

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 957

Group type: EXPERIMENTAL
Intervention: Semaglutide (0.1 mg or more)
Number of subjects: 957
Study: 26639678

Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine/naloxone (BNX)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Oral naltrexone (NTX)
Number of subjects: 102
Study: 23561959

Group type: EXPERIMENTAL
Intervention: Autologous bone marrow-derived stem cell transplantation (ABMSCT)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham procedure (Control)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: ABMSCT
Number of subjects: 21
Study: 22341794

Group type: EXPERIMENTAL
Intervention: EBRT+HDR-BTb
Number of subjects: 218

Group type: COMPARATOR
Intervention: EBRT alone
Number of subjects: 218
Study: 21216832

Group type: EXPERIMENTAL
Intervention: Endocardial LV pacing from the best endocardial site
Number of subjects: 15

Group type: COMPARATOR
Intervention: Conventional CRT
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: All LV pacing modes
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: LV stimulation outside areas of slow conduction
Number of subjects: 15
Study: 18647128

Group type: EXPERIMENTAL
Intervention: CBGT+EX (exercise-enhanced cognitive behavioural group therapy)
Number of subjects: 73

Group type: COMPARATOR
Intervention: CBGT+ED (usual cognitive behavioural group therapy plus nutrition education)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: CBGT+EX
Number of subjects: 73
Study: 16948354

Group type: EXPERIMENTAL
Intervention: Montelukast, 5-mg tablets for 1 month
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Montelukast, before treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 12974853

Group type: EXPERIMENTAL
Intervention: Cementation with 100 N seating force (Group 1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cementation with 10 N force and dentine sealing (Group 2)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cementation with 10 N force, dentine sealing, and oscillating seating force (Group 3)
Number of subjects: 30
Study: 10920334

Group type: EXPERIMENTAL
Intervention: Cord blood collection before placental delivery
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cord blood collection after placental delivery
Number of subjects: 40
Study: 8824057

Group type: EXPERIMENTAL
Intervention: Amitriptyline (AMI), 5 mg/kg per day
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 1411286

Group type: EXPERIMENTAL
Intervention: Hemoccult‐II screening
Number of subjects: 61938
Study: 6726307

Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Supportive counseling
Number of subjects: 51

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 51
Study: 31092695

Group type: EXPERIMENTAL
Intervention: ACCi-1 (acetyl-CoA carboxylase inhibitor), dosed orally for 2 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ACCi-1 (acetyl-CoA carboxylase inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Individuals with acne vulgaris
Number of subjects: 0
Study: 29214348

Group type: EXPERIMENTAL
Intervention: Laser-assisted hatching
Number of subjects: 308

Group type: COMPARATOR
Intervention: No laser-assisted hatching
Number of subjects: 308
Study: 26338465

Group type: EXPERIMENTAL
Intervention: CogniPlus program combined with balance training
Number of subjects: 80

Group type: COMPARATOR
Intervention: Balance training alone
Number of subjects: 80
Study: 25230962

Group type: EXPERIMENTAL
Intervention: Intracameral dexamethasone (0.4 mg/0.1 ml)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intracameral triamcinolone acetonide (2 mg/0.05 ml)
Number of subjects: 60
Study: 22617588

Group type: EXPERIMENTAL
Intervention: Excessive early gestational weight gain
Number of subjects: 7985

Group type: COMPARATOR
Intervention: Nonexcessive early gestational weight gain
Number of subjects: 7985
Study: 20470679

Group type: EXPERIMENTAL
Intervention: 3D computer model group (n = 50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard written instruction group (SWI group) (n = 50)
Number of subjects: 100
Study: 18006530

Group type: EXPERIMENTAL
Intervention: Remifentanil at target Ce of 4 ng ml(‐1)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Remifentanil at target Ce of 6 ng ml(‐1)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Remifentanil at target Ce of 2 ng ml(‐1)
Number of subjects: 128
Study: 16102942

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 0
Study: 12230319

Group type: EXPERIMENTAL
Intervention: Growth hormone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glutamine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GLP-2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary management
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intestinal transplant
Number of subjects: 0
Study: 10200006

Group type: EXPERIMENTAL
Intervention: Loratadine (10 mg daily)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Cetirizine (10 mg daily)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 7774173

Group type: EXPERIMENTAL
Intervention: Glass ionomer cement (GIC) applied by dentist
Number of subjects: 1264

Group type: EXPERIMENTAL
Intervention: Glass ionomer cement (GIC) applied by trained teachers
Number of subjects: 1264

Group type: EXPERIMENTAL
Intervention: 0.5% HF solution applied three times
Number of subjects: 1264

Group type: EXPERIMENTAL
Intervention: Delton resin-based sealant
Number of subjects: 1264

Group type: EXPERIMENTAL
Intervention: GIC applied by dentist (12-13 yr-olds)
Number of subjects: 1264

Group type: EXPERIMENTAL
Intervention: GIC applied by teachers (12-13 yr-olds)
Number of subjects: 1264

Group type: EXPERIMENTAL
Intervention: 0.5% HF solution (12-13 yr-olds)
Number of subjects: 1264

Group type: COMPARATOR
Intervention: Control group (younger age group)
Number of subjects: 1264

Group type: COMPARATOR
Intervention: Control group (12-13 yr-olds)
Number of subjects: 1264
Study: 2182310

Group type: EXPERIMENTAL
Intervention: RU486 alone (600mg in a single oral dose)
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: RU486 and PG (1 mg suppository)
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: RU486 and PG
Number of subjects: 316

Group type: COMPARATOR
Intervention: RU486 alone
Number of subjects: 316
Study: 7356891

Group type: EXPERIMENTAL
Intervention: 160 mg propranolol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 160 mg L.A. propranolol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: L.A. propranolol
Number of subjects: 10
Study: 30770892

Group type: EXPERIMENTAL
Intervention: Delta-9-tetrahydrocannabinol (Δ9-THC; 1.19 mg/2 ml)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Delta-9-tetrahydrocannabinol (Δ9-THC)
Number of subjects: 16
Study: 30739626

Group type: EXPERIMENTAL
Intervention: 250 mg/d Mg as magnesium oxide (n=27)
Number of subjects: 54
Study: 28936036

Group type: EXPERIMENTAL
Intervention: Mandibular dentures with soft denture liner
Number of subjects: 28

Group type: COMPARATOR
Intervention: Mandibular dentures without soft denture liner (control)
Number of subjects: 28
Study: 25912390

Group type: EXPERIMENTAL
Intervention: Staged PCI
Number of subjects: 125
Study: 23721562

Group type: EXPERIMENTAL
Intervention: Maudsley Model of Treatment for Adults with Anorexia Nervosa (MANTRA)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Specialist Supportive Clinical Management (SSCM)
Number of subjects: 138
Study: 20336636

Group type: EXPERIMENTAL
Intervention: Problem-Solving Therapy (PST)
Number of subjects: 98
Study: 19448203

Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch (HES) 130/0.4
Number of subjects: 115

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 115
Study: 17106140

Group type: EXPERIMENTAL
Intervention: CR‐ISMN (40 mg once daily)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 12751378

Group type: EXPERIMENTAL
Intervention: Stereotactic radiosurgery (SR)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Whole brain irradiation (WBI)
Number of subjects: 94

Group type: COMPARATOR
Intervention: High-dose interleukin-2 (IL-2) and interferon-alpha (IFN-alpha) therapy
Number of subjects: 94

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 94
Study: 10846781

Group type: EXPERIMENTAL
Intervention: Bacterial vaginosis (36 patients, 32%)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Normal flora (76 patients, 68%)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Cervical length < 25 mm
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Overall preterm delivery rate
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Cervical length measured by transvaginal ultrasonography
Number of subjects: 112
Study: 9322520

Group type: EXPERIMENTAL
Intervention: 25 mg of lamivudine
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 100 mg of lamivudine
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 300 mg of lamivudine
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Lamivudine (all doses)
Number of subjects: 51
Study: 8436459

Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 22

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 22
Study: 3087293

Group type: EXPERIMENTAL
Intervention: Chemoimmunotherapy with MMC, 5‐FU and OK‐432 (group B)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Chemotherapy with MMC and 5‐FU (group A)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Surgery alone (group C)
Number of subjects: 99
Study: 29022746

Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg
Number of subjects: 2313

Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg
Number of subjects: 2313

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2313
Study: 27367724

Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation (Lactobacillus reuteri with guar gum and inulin for three months)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Nutritional counseling alone
Number of subjects: 50